Comparative analysis of expression profiles of TERC and TERT in two groups of patients showed a statistically significant increase only in the expression of TERT in the CML-BP group of patients (Fig. 2a–b). This evidence concerns the gene TERC and chronic myelogenous leukemia, BCR-ABL1 positive.